NRGENE TECHNOLOGIES LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 401.6 ILa | -4.90% |
|
-13.00% | +129.35% |
| Mar. 20 | NRGene Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 30 | NRgene Technologies Ltd. Establishes Supree | CI |
| Sales 2022 | 3.16M 1.16B | Sales 2023 | 2M 736M | Capitalization | 6.07M 2.23B |
|---|---|---|---|---|---|
| Net income 2022 | -6M -2.21B | Net income 2023 | -5M -1.84B | EV / Sales 2022 | 1.71 x |
| Net cash position 2022 | 10.67M 3.93B | Net cash position 2023 | 4.75M 1.75B | EV / Sales 2023 | 0.66 x |
| P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.15
x | Employees | 50 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.90% | ||
| 1 week | -13.00% | ||
| Current month | -32.23% | ||
| 1 month | -31.07% | ||
| 3 months | +23.84% | ||
| 6 months | +96.67% | ||
| Current year | +129.35% |
1 week
400.00
453.50
1 month
400.00620.00
Current year
191.60640.00
1 year
155.00640.00
3 years
155.001 851.00
5 years
155.003 080.00
10 years
155.003 080.00
| Managers | Title | Age | Since |
|---|---|---|---|
Gil Ronen
FOU | Founder | 56 | 09-02-08 |
Ehud Belder Chen
DFI | Director of Finance/CFO | 39 | 18-09-30 |
| Chief Tech/Sci/R&D Officer | 48 | 11-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rafael Berber
BRD | Director/Board Member | 62 | 16-09-03 |
Gil Ronen
FOU | Founder | 56 | 09-02-08 |
Oren Mohar
BRD | Director/Board Member | 53 | 21-04-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 401.6 | -4.90% | 3,450 |
| 24-05-27 | 422.3 | -6.86% | 3,511 |
| 24-05-23 | 453.4 | -0.53% | 479 |
| 24-05-22 | 455.8 | -1.26% | 15,760 |
| 24-05-21 | 461.6 | +0.02% | 1,203 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 28, 2024 at 10:24 am EDT
More quotes
Nrgene Technologies Ltd, formerly EnerginR Technologies 2009 Ltd, is an Israel-based biotechnology company. Nrgene Technologies Ltd is principally engaged in agricultural technology (AgTech) industry. The Company is engaged in the research and development and applying of its technology in the field of artificial intelligence, including software tools, in order to analyze genetic information based on Big Data, for the acceleration and improvement of natural breeding of crops and animals in the global agriculture and food industry. Company's product portfolio includes customized, all-inclusive genotyping solution such as, SnPer, SnPro, Soy SNProm Canola Pro. Nrgene Technologies Ltd operates and serves its customers globally.
Sector
Software
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +129.35% | 14.65M | |
| -25.91% | 25.72B | |
| +28.08% | 11.91B | |
| -0.65% | 5.06B | |
| -11.90% | 848M | |
| +6.56% | 531M | |
| -19.15% | 414M | |
| +36.61% | 381M | |
| 0.00% | 299M | |
| -19.70% | 243M |
- Stock Market
- Equities
- NRGN Stock
